Upcoming IPOs to Watch This Week Include MRT, NTNX, FLGT

upcoming IPOsWe have another busy IPO calendar for the week of Sept. 26, with five upcoming IPOs expected to raise a combined $562 million. That's according to Renaissance Capital, a manager of IPO-focused ETFs.

The five companies on the IPO calendar this week include a tech company, three companies in the healthcare market, and communications provider.

The largest upcoming IPO this week is MedEquities Realty Trust (NYSE: MRT).

MedEquities is a REIT that was formed in 2014 to invest in healthcare-related real estate debt and the healthcare industry. Its portfolio includes 24 healthcare facilities located in California, Texas, South Carolina, and Nevada.

The company's strategy, according to its website, is to become capital partners with "high-quality, facility-based, growth-minded providers of healthcare services."

MedEquities currently has a 6.5% annualized yield. It wants to raise $259 million dollars in its upcoming IPO by selling 19.9 million shares for $12 to $14 per share.

The rest of this week's upcoming IPOs include one company that could revolutionize genetic testing services...

4 Other Must-Watch Upcoming IPOs This Week

Full Spectrum (Nasdaq: FMAX) was supposed to have its IPO the week of Sept. 5, but it has been pushed back to this week. Full Spectrum was founded in 2006 and is a privately held Delaware corporation. It has a niche in the cellular market, where it develops and sells products used to make private cellular networks.

Trending: The Uber IPO Date Just Hit a Major Roadblock

The cellular company manufactures a state-of-the-art wireless radio system known as FullMAX. Full Spectrum had $1 million in sales from June 30, 2015, to June 30, 2016. Full Spectrum hopes to raise $15 million by offering close to 2 million shares at $7 to $9 per share.

Continue reading for the three other upcoming IPOs this week that investors need to watch...

[mmpazkzone name="in-story" network="9794" site="307044" id="137008" type="4"]

Tabula Rasa HealthCare (Nasdaq: TRHC) uses data-driven technology and patient-specific data to help healthcare organizations optimize medication regimes. The data is used to help healthcare organizations lower healthcare costs, manage risks, improve patient outcomes, and reduce hospitalizations.

Founder Dr. Calvin H. Knowlton received the Greater Philadelphia region's E&Y Entrepreneur of the Year award in 2013. He also received the Philadelphia Alliance for Capital & Technologies award for Technology CEO of the Year in 2016. Tabula Rasa hopes to raise $60 million by selling 4.3 million shares between $13 and $15 per share.

Nutanix (Nasdaq: NTNX) is a California-based tech company that originally filed for an IPO in December. But Nutanix decided to wait for better market conditions before going public. It's one of the leaders in a growing market called "hyperconverged" networking. Nutanix is considered a trailblazer for combining storage and computer servers in one unit. According to Fortune, these devices have traditionally been separated in their own sections of a data center. Combining the two is supposed to make managing the servers and storage easier for corporate customers.

Nutanix is considered a unicorn IPO, because it has private valuations of over $1 billion. It's looking to raise $168 million by selling shares between $11 and $13.

Fulgent Genetics (Nasdaq: FLGT) is a technology-based genetic testing company. It provides physicians with diagnostic information that can be used to improve the quality of patient care. It has a proprietary technology platform that uses sophisticated data and algorithms to offer a broad and flexible test menu. The company believes its test menu offers more genes for testing than its competitors. The test menu currently includes more than 18,000 single-gene tests.

Fulgent's sales grew by 82% in Q2 to almost $4 million. Fulgent will try to raise $60 million by selling 4.6 million shares at $12 to $14.

Up Next: Get the Best Investing Research Today to Grow Your Money

Follow us on Twitter @moneymorning and like us on Facebook.